Investmark Advisory Group LLC Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Investmark Advisory Group LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 25.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 544 shares of the healthcare conglomerate’s stock after selling 187 shares during the quarter. Investmark Advisory Group LLC’s holdings in UnitedHealth Group were worth $275,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $6,375,744,000. Raymond James Financial Inc. purchased a new stake in UnitedHealth Group in the 4th quarter valued at $1,914,740,000. Amundi boosted its stake in UnitedHealth Group by 97.2% during the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the period. Finally, Proficio Capital Partners LLC boosted its stake in shares of UnitedHealth Group by 76,830.4% during the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock worth $955,388,000 after buying an additional 1,886,186 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have commented on UNH shares. Wolfe Research reduced their price objective on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research note on Tuesday. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 22nd. TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective for the company. in a research report on Monday. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. One analyst has rated the stock with a sell rating, seven have issued a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $441.87.

Get Our Latest Stock Analysis on UNH

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex purchased 17,175 shares of the stock in a transaction on Friday, May 16th. The stock was bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the acquisition, the chief financial officer now directly owns 203,796 shares of the company’s stock, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of the firm’s stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 5.8%

Shares of UNH stock opened at $303.08 on Thursday. The stock has a market cap of $274.93 billion, a P/E ratio of 19.55, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The business has a fifty day simple moving average of $460.62 and a 200-day simple moving average of $508.74. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period last year, the company earned $6.91 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.77%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 35.18%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.